Tui Na Acupressure Modulates Treg Immunosuppression via FoxP3 / mTORC1 Signalling in ALS Mice
Immunology · 2026
DOI: 10.1111/imm.70052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, 2026. Verfasst von Jie Han und 7 weiteren Autor:innen. Beteiligte Einrichtung: Rehabilitation Medicine Center/Tuina Department, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Mechanistic Target of Rapamycin Complex 1, Amyotrophic Lateral Sclerosis, Forkhead Transcription Factors. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hubei Provincial Natural Science Foundation's Innovation, Development Joint Fund Project, Science and Technology Special Project of the State Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease driven by neuroinflammation, where regulatory T cell (Treg) dysfunction exacerbates immune imbalance. This study explores whether Tui Na acupressure, a traditional Chinese therapy, can restore Treg immunosuppressive function through the FoxP3/mTORC1 signalling pathway to mitigate ALS pathology. In SOD1G93A ALS mice, Tui Na was applied at the Shenshu acupoint, with motor and cognitive functions assessed via rotarod, tail suspension, novel object recognition, and Y‐maze tests. Multi‐omics (transcriptomics, proteomics), flow cytometry, ELISA, and Western blot analysed Treg proportions, cytokine profiles, and pathway activation. In vitro assays evaluated Treg proliferation and immunosuppression. Tui Na significantly enhanced motor and cognitive performance, increased Treg proportions in spleen, lymph nodes, and blood, and elevated anti‐inflammatory cytokines (IL‐10, TGF‐β) while reducing pro‐inflammatory markers (IL‐6, TNF‐α). Transcriptomic and proteomic analyses revealed upregulated FoxP3, Mtor, and Raptor, with enhanced Treg proliferation and immunosuppression confirmed in vitro. Pathway inhibitors (GSK126, rapamycin) reversed these effects, confirming FoxP3/mTORC1 dependency. Tui Na also reduced apoptosis and oxidative stress, supporting immune regulation. These findings highlight Tui Na's potential to restore Treg‐mediated immune balance in ALS, offering a non‐pharmacological therapeutic strategy. This study provides novel immunological insights into Tui Na's mechanisms, advocating its clinical evaluation for ALS and related immune‐driven disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rehabilitation Medicine Center/Tuina Department, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China.
- Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, China.
- Hubei Shizhen Laboratory, Wuhan, China.
- Hubei Key Laboratory of the theory and application research of liver and kidney in traditional Chinese medicine, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China.
- The First Clinical Medical College, Hubei University of Chinese Medicine, Wuhan, China.
ORCID-Profile: Xi Xu
Förderung
- Hubei Provincial Natural Science Foundation's Innovation
- Development Joint Fund Project
- Science and Technology Special Project of the State Administration of Traditional Chinese Medicine
Zitieren
APA
Han, J., Xu, X., Zhao, Y., Xiao, Y., Huang, F., Zhou, J., Huang, H., & Wang, G. (2026). Tui Na Acupressure Modulates Treg Immunosuppression via FoxP3 / mTORC1 Signalling in ALS Mice. Immunology. https://doi.org/10.1111/imm.70052
Vancouver
Han J, Xu X, Zhao Y, Xiao Y, Huang F, Zhou J, et al. Tui Na Acupressure Modulates Treg Immunosuppression via FoxP3 / mTORC1 Signalling in ALS Mice. Immunology. 2026. doi:10.1111/imm.70052
BibTeX
@article{Han2026,
author = {Han, Jie and Xu, Xi and Zhao, Yan and Xiao, Yao and Huang, Fei and Zhou, Jing and Huang, Hai and Wang, Guiqian},
title = {Tui Na Acupressure Modulates Treg Immunosuppression via FoxP3 / mTORC1 Signalling in ALS Mice},
journal = {Immunology},
year = {2026},
doi = {10.1111/imm.70052}
}
EUVIMED